TO

TORII PHARMACEUTICAL CO., LTD.

Develops and markets drugs for renal diseases, skin diseases, HIV, and allergies.

4551 | T

Overview

Corporate Details

ISIN(s):
JP3635800000
LEI:
Country:
Japan
Address:
中央区日本橋本町三丁目4番1号

Description

Torii Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the development, manufacturing, and marketing of prescription drugs. The company's primary focus is on therapeutic agents for renal diseases and hemodialysis, particularly for chronic kidney disease (CKD). Its portfolio also includes products for skin diseases, HIV, and allergies. Torii Pharmaceutical utilizes strategic partnerships and promotes medical products from its parent company, Japan Tobacco, to provide specialized pharmaceutical solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2019-11-01 01:02
四半期報告書-第128期第3四半期(2019/07/01-2019/09/30)
Japanese ZIP 157.9 KB
2019-08-01 02:07
四半期報告書-第128期第2四半期(2019/04/01-2019/06/30)
Japanese ZIP 195.4 KB
2019-04-26 02:00
四半期報告書-第128期第1四半期(2019/01/01-2019/03/31)
Japanese ZIP 149.0 KB
2019-03-26 05:24
有価証券報告書-第127期(平成30年1月1日-平成30年12月31日)
Japanese ZIP 702.4 KB
2018-11-01 01:02
四半期報告書-第127期第3四半期(2018/07/01-2018/09/30)
Japanese ZIP 141.0 KB
2018-08-07 02:00
四半期報告書-第127期第2四半期(2018/04/01-2018/06/30)
Japanese ZIP 170.9 KB
2018-05-08 02:29
四半期報告書-第127期第1四半期(2018/01/01-2018/03/31)
Japanese ZIP 131.3 KB
2018-03-28 06:11
有価証券報告書-第126期(平成29年1月1日-平成29年12月31日)
Japanese ZIP 655.3 KB
2017-11-07 01:24
四半期報告書-第126期第3四半期(2017/07/01-2017/09/30)
Japanese ZIP 136.5 KB
2017-08-08 02:38
四半期報告書-第126期第2四半期(2017/04/01-2017/06/30)
Japanese ZIP 165.8 KB
2017-05-09 02:11
四半期報告書-第126期第1四半期(2017/01/01-2017/03/31)
Japanese ZIP 131.2 KB
2017-03-24 05:06
有価証券報告書-第125期(2016/01/01-2016/12/31)
Japanese ZIP 676.0 KB
2016-11-08 01:17
四半期報告書-第125期第3四半期(2016/07/01-2016/09/30)
Japanese ZIP 140.4 KB
2016-08-02 06:19
四半期報告書-第125期第2四半期(2016/04/01-2016/06/30)
Japanese ZIP 200.4 KB
2016-05-10 06:21
四半期報告書-第125期第1四半期(2016/01/01-2016/03/31)
Japanese ZIP 142.8 KB

Automate Your Workflow. Get a real-time feed of all TORII PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TORII PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TORII PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.